
Flomerics India Private Limited
Founded in 2004 and headquartered in Maharashtra, India.
Founded in 2004 and headquartered in Maharashtra, India.
Raigarh, Maharashtra, India
+91-XXXXXXXXXX
U72200MH2004PTC144781
144781
Private Limited Indian Non-Government Company
27 Feb 2004
14 Jul 2021
31 Mar 2021
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhijit Ray ![]() | Director | 19-Jan-2018 | Current |
Sridhar Subramaniam ![]() | Director | 28-Aug-2017 | Current |
Flomerics India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Flomerics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sridhar Subramaniam is a mutual person
Sridhar Subramaniam and Abhijit Ray are mutual person
Sridhar Subramaniam and Abhijit Ray are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Flomerics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Flomerics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flomerics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Flomerics India Private Limited last Annual general meeting of members was held on 14 Jul 2021 as per latest MCA records.
Flomerics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.
Abhijit Ray was appointed as a Director was appointed as a Director on 19 Jan 2018 & has been associated with this company since 7 years 3 months .
Sridhar Subramaniam was appointed as a Director was appointed as a Director on 28 Aug 2017 & has been associated with this company since 7 years 8 months .
Flomerics India Private Limited was registered on 27 Feb 2004 with Roc Mumbai & aged 21 years 2 months as per MCA records.
Flomerics India Private Limited was incorporated on 27 Feb 2004.
The authorized share capital of Flomerics India Private Limited is ₹ 4.15 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Flomerics India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Flomerics India Private Limited is Plot No.2 Sector No. 2, Kharghar Node, Navi Mumbai Mumbai City, Maharashtra, India, 410210.
The corporate identification number (CIN) of Flomerics India Private Limited is U72200MH2004PTC144781 and the company number is 144781 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Flomerics India Private Limited was filed with the ROC on 31 Mar 2021.
Search company & director profiles for free and gain access to critical business data.
PN
GC
RN
BE
CO